Qiagen NV
XETRA:QIA
Qiagen NV
XETRA:QIA
Price:
41.065
EUR
-0.56%
Market Closed
Market Cap:
€9.3B
Relative Value
The Relative Value of one
QIA
stock under the Base Case scenario is
49.633
EUR.
Compared to the current market price of 41.065 EUR,
Qiagen NV
is
Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QIA
Relative Value
Base Case
49.633
EUR
Undervaluation 17%
Multiples Across Competitors
QIA Competitors Multiples
Qiagen NV Competitors
Qiagen NV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NL |
|
Qiagen NV
XETRA:QIA
|
10.2B EUR | 4.9 | 24.3 | 15.2 | 20.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 367.7 | 4 354.1 | 1 380.5 | 2 949.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
190.4B USD | 4.3 | 28.4 | 19.8 | 26.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
144.6B USD | 5.9 | 39.9 | 20.2 | 29.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 15 | 51.6 | 30.3 | 40.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.7B CHF | 5.5 | 37.6 | 27.9 | 27.9 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
272.4B CNY | 6.1 | 18.2 | 18.3 | 18.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.6B USD | 4.7 | 26 | 20.4 | 24.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.5B USD | 9.6 | 47.4 | 30.6 | 38.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.6B USD | 1.8 | 21.8 | 12.1 | 18.1 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 6.7 | 30.8 | 22.8 | 25.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
